| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 6 |
| NetGPI | no | yes: 0, no: 6 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005634 | nucleus | 5 | 2 |
| GO:0005730 | nucleolus | 5 | 2 |
| GO:0043226 | organelle | 2 | 2 |
| GO:0043227 | membrane-bounded organelle | 3 | 2 |
| GO:0043228 | non-membrane-bounded organelle | 3 | 2 |
| GO:0043229 | intracellular organelle | 3 | 2 |
| GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
| GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 2 |
| GO:0110165 | cellular anatomical entity | 1 | 3 |
| GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: Q4Q2N0
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003676 | nucleic acid binding | 3 | 7 |
| GO:0005488 | binding | 1 | 7 |
| GO:0008270 | zinc ion binding | 6 | 7 |
| GO:0043167 | ion binding | 2 | 7 |
| GO:0043169 | cation binding | 3 | 7 |
| GO:0046872 | metal ion binding | 4 | 7 |
| GO:0046914 | transition metal ion binding | 5 | 7 |
| GO:0097159 | organic cyclic compound binding | 2 | 7 |
| GO:1901363 | heterocyclic compound binding | 2 | 7 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 199 | 203 | PF00656 | 0.788 |
| CLV_C14_Caspase3-7 | 232 | 236 | PF00656 | 0.711 |
| CLV_NRD_NRD_1 | 13 | 15 | PF00675 | 0.727 |
| CLV_NRD_NRD_1 | 16 | 18 | PF00675 | 0.730 |
| CLV_NRD_NRD_1 | 9 | 11 | PF00675 | 0.723 |
| CLV_PCSK_FUR_1 | 14 | 18 | PF00082 | 0.745 |
| CLV_PCSK_KEX2_1 | 13 | 15 | PF00082 | 0.707 |
| CLV_PCSK_KEX2_1 | 16 | 18 | PF00082 | 0.706 |
| CLV_PCSK_KEX2_1 | 243 | 245 | PF00082 | 0.568 |
| CLV_PCSK_KEX2_1 | 9 | 11 | PF00082 | 0.731 |
| CLV_PCSK_PC1ET2_1 | 243 | 245 | PF00082 | 0.568 |
| CLV_PCSK_PC7_1 | 5 | 11 | PF00082 | 0.735 |
| DOC_PP4_FxxP_1 | 131 | 134 | PF00568 | 0.491 |
| DOC_USP7_MATH_1 | 231 | 235 | PF00917 | 0.713 |
| LIG_14-3-3_CanoR_1 | 21 | 25 | PF00244 | 0.760 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.731 |
| LIG_BRCT_BRCA1_1 | 172 | 176 | PF00533 | 0.575 |
| LIG_deltaCOP1_diTrp_1 | 126 | 131 | PF00928 | 0.481 |
| LIG_FHA_1 | 134 | 140 | PF00498 | 0.532 |
| LIG_FHA_1 | 153 | 159 | PF00498 | 0.364 |
| LIG_FHA_1 | 216 | 222 | PF00498 | 0.702 |
| LIG_LIR_Apic_2 | 130 | 134 | PF02991 | 0.479 |
| LIG_LIR_Gen_1 | 118 | 129 | PF02991 | 0.537 |
| LIG_LIR_Nem_3 | 118 | 124 | PF02991 | 0.570 |
| LIG_LIR_Nem_3 | 126 | 132 | PF02991 | 0.485 |
| LIG_LIR_Nem_3 | 62 | 67 | PF02991 | 0.605 |
| LIG_LYPXL_yS_3 | 78 | 81 | PF13949 | 0.605 |
| LIG_PCNA_PIPBox_1 | 99 | 108 | PF02747 | 0.576 |
| LIG_PCNA_yPIPBox_3 | 99 | 108 | PF02747 | 0.602 |
| LIG_Pex14_1 | 128 | 132 | PF04695 | 0.479 |
| LIG_SH2_GRB2like | 141 | 144 | PF00017 | 0.503 |
| LIG_SH2_SRC | 141 | 144 | PF00017 | 0.503 |
| LIG_SH2_STAT5 | 105 | 108 | PF00017 | 0.564 |
| LIG_SH2_STAT5 | 164 | 167 | PF00017 | 0.492 |
| LIG_SH2_STAT5 | 67 | 70 | PF00017 | 0.559 |
| MOD_CK1_1 | 144 | 150 | PF00069 | 0.569 |
| MOD_CK1_1 | 20 | 26 | PF00069 | 0.602 |
| MOD_CK1_1 | 201 | 207 | PF00069 | 0.713 |
| MOD_CK1_1 | 208 | 214 | PF00069 | 0.709 |
| MOD_CK1_1 | 215 | 221 | PF00069 | 0.768 |
| MOD_CK1_1 | 222 | 228 | PF00069 | 0.706 |
| MOD_CK1_1 | 230 | 236 | PF00069 | 0.566 |
| MOD_CK1_1 | 33 | 39 | PF00069 | 0.732 |
| MOD_CK1_1 | 4 | 10 | PF00069 | 0.817 |
| MOD_CK2_1 | 9 | 15 | PF00069 | 0.779 |
| MOD_GlcNHglycan | 172 | 175 | PF01048 | 0.492 |
| MOD_GlcNHglycan | 227 | 230 | PF01048 | 0.772 |
| MOD_GlcNHglycan | 244 | 247 | PF01048 | 0.597 |
| MOD_GlcNHglycan | 32 | 35 | PF01048 | 0.729 |
| MOD_GlcNHglycan | 95 | 98 | PF01048 | 0.607 |
| MOD_GSK3_1 | 194 | 201 | PF00069 | 0.732 |
| MOD_GSK3_1 | 202 | 209 | PF00069 | 0.759 |
| MOD_GSK3_1 | 211 | 218 | PF00069 | 0.560 |
| MOD_GSK3_1 | 219 | 226 | PF00069 | 0.666 |
| MOD_GSK3_1 | 227 | 234 | PF00069 | 0.517 |
| MOD_GSK3_1 | 29 | 36 | PF00069 | 0.793 |
| MOD_NEK2_1 | 1 | 6 | PF00069 | 0.831 |
| MOD_NEK2_1 | 181 | 186 | PF00069 | 0.567 |
| MOD_PIKK_1 | 144 | 150 | PF00454 | 0.569 |
| MOD_PIKK_1 | 95 | 101 | PF00454 | 0.586 |
| MOD_PKA_1 | 17 | 23 | PF00069 | 0.705 |
| MOD_PKA_1 | 9 | 15 | PF00069 | 0.732 |
| MOD_PKA_2 | 20 | 26 | PF00069 | 0.550 |
| MOD_PKA_2 | 222 | 228 | PF00069 | 0.620 |
| MOD_PKA_2 | 30 | 36 | PF00069 | 0.622 |
| MOD_PKA_2 | 4 | 10 | PF00069 | 0.752 |
| MOD_Plk_1 | 144 | 150 | PF00069 | 0.569 |
| MOD_Plk_1 | 216 | 222 | PF00069 | 0.702 |
| MOD_Plk_4 | 157 | 163 | PF00069 | 0.488 |
| MOD_SUMO_rev_2 | 127 | 136 | PF00179 | 0.569 |
| MOD_SUMO_rev_2 | 235 | 245 | PF00179 | 0.561 |
| TRG_ENDOCYTIC_2 | 78 | 81 | PF00928 | 0.605 |
| TRG_NLS_Bipartite_1 | 9 | 29 | PF00514 | 0.665 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P2M7 | Leptomonas seymouri | 71% | 99% |
| A0A3S7X890 | Leishmania donovani | 89% | 100% |
| A4HB33 | Leishmania braziliensis | 87% | 100% |
| A4IAN6 | Leishmania infantum | 90% | 100% |
| E9B5A3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |